IQM Quantum Computers (IQMX) reported a third-quarter loss of $0.93 per share on revenue of $10.19 million, its first quarterly report since its July Nasdaq listing. There was no consensus estimate to measure against, so the headline matters less than the order book. Q3 order intake was a record €42.2 million, compared with €10.6 million for all of the first half. That lifted backlog to €102.5 million from €69.1 million at the end of June. The central tension is that IQM proved it can sign larger, more strategic contracts. It reiterated rather than raised full-year guidance, however, and that guidance now depends on an unusually heavy fourth quarter.

The reported loss needs context. In euros, the loss per share was €0.81, compared with €0.41 a year earlier. The €152.6 million net loss was dominated by a €127.1 million non-cash share listing expense, plus listing-related transaction costs that management says have now been fully recorded. Even so, the underlying cost base has stepped up sharply.

• General and administrative expense rose to €27.0 million from €2.7 million in the year-ago quarter, with share-based payments a growing factor.
• Selling expense roughly tripled to €4.3 million.
• R&D climbed to €20.4 million from €13.7 million.

On the top line, revenue grew 51% year over year to €8.9 million, a touch faster than the 49% pace for the first nine months. It also rose sequentially from €6.7 million in Q2. The CFO stressed that revenue came entirely from commercial contracts, with no grants included. Gross margin edged up to 47% from 46%, a modest improvement rather than an inflection.

The call made clear that commercial breadth is widening:

• **Largest deal to date.** The €33 million LUMI-IQ contract with CSC's LUMI AI Factory is the first order for IQM's Halocene error-correction platform. Its value is roughly equal to all of IQM's 2025 revenue, with staged deliveries running from 2027 through 2029.
• **New and repeat customers.** IQM made its first sale in South America (Brazil's Eldorado Research Institute), won a repeat order from TOYO in Japan, booked a post-quarter order from the Community of Madrid, and included unannounced orders in Q3 intake.
• **Unit growth.** Cumulative systems sold rose to 31 from 26, and systems in production nearly doubled to 17 from 8.
• **Sovereign programs.** IQM advanced in Germany's up-to-€640 million quantum competition and the EU Grand Challenge, and is part of a NEDO project in Japan. These add funding optionality.

The catch is conversion. Larger contracts like LUMI-IQ stretch the time from order to revenue beyond two years. Only €59.5 million of the backlog is expected to convert within 12 months.

That makes Q4 the real test. Nine-month revenue of €17.7 million leaves roughly €20 million to €25 million needed in the fourth quarter to reach the €42 million to €47 million guidance. That would be more than double any quarter to date. Revenue is recognized on customer acceptance, which depends partly on factors outside IQM's control, such as site readiness, cooling and power infrastructure, and public-sector sign-off. The release itself warns that a few weeks' slippage can push revenue across a quarter-end. There is already one slip on record: a two-system Spanish contract expected in June has moved to early 2027. Partly offsetting that risk, the first two 150-qubit systems have shipped and are being installed, with final delivery targeted by year-end. The full-year order-intake target of €65 million to €75 million also implies backlog will drift toward roughly €90 million by year-end unless orders outpace guidance.

Cash is the other pressure point. Cash fell to €260.4 million from €309.4 million after the listing, driven by a €48.3 million Q3 operating outflow, one-time listing costs and fab investment. Year-to-date operating cash outflow is about €98.5 million. Management cited runway into Q2 2028 but declined to quantify normalized burn or its 2027–2028 revenue assumptions. That leaves investors to model the spending trajectory themselves at a time when inventories have swelled to €34.3 million from €13.5 million ahead of deliveries.

The market had already turned skeptical before the report.

• **Price trend.** Shares entered the release at $8.80, down 13.3% since the opening after the August report and 29% below the inter-earnings high of $12.43 set in late August.
• **Technical position.** The stock sat 14% below its 200-day moving average and only about 6% above a 52-week low of $8.33 set just three days before earnings.
• **Sentiment.** Earnings Whispers investor sentiment stood at a decidedly negative -0.63.
• **Trend readings.** The internal trend readings lean negative, with AVWAP among the weak signals.

That backdrop suggests investors were focused on cash burn and delivery risk rather than bookings. A record backlog quarter does not automatically dislodge that concern.

The bottom line is that IQM delivered the commercial validation it needed: a record bookings quarter, a first error-correction platform order, and a broader global customer base. It did not deliver financial validation. With guidance merely reiterated, a back-end-loaded revenue plan tied to customer acceptance, a Spanish delivery already slipped, and no clarity on normalized burn, bears have legitimate ammunition. Q4 acceptance of the 150-qubit systems will determine whether the backlog story translates into credibility.